MW
RPRX icon

MBL Wealth’s Royalty Pharma RPRX Stock Holding History

MBL Wealth’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204K Buy
+3,642
New +$190K 0.01% 374

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
KMC
Kirr Marbach & Co Columbus, Indiana $594M AUM 34% 1-Year Est. Return

MBL Wealth's RPRX Position: Q2 2026 in Review

MBL Wealth opened a new position in Royalty Pharma (RPRX) in Q2 2026: 3,642 shares worth $204K. The stake represents 0.01% of the portfolio and ranks #374 among its holdings.

130 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • MBL Wealth held 3,642 shares of Royalty Pharma worth $204K as of Q2 2026.
  • Royalty Pharma was a new MBL Wealth position in Q2 2026.
  • Royalty Pharma made up 0.01% of MBL Wealth's portfolio in Q2 2026, its #374 holding.
  • 130 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on MBL Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.